Research has shown that p53 can suppress the expression of SLC7A11, a key component of the cystine/glutamate antiporter (X c system), leading to the inhibition of cystine uptake and sensitization to ferroptosis
These patterns raise concerns that treatment decisions could be influenced more by demographic factors, particularly BMI, age and sex, than by objective clinical need
Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around your genetic predispositions in GLP1R, GIPR, FTO, and MC4R variantsregions associated with peptide pathway sensitivity and metabolic response
Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome